139 related articles for article (PubMed ID: 19755854)
21. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.
Tan J; Newton CA; Djeu JY; Gutsch DE; Chang AE; Yang NS; Klein TW; Hua Y
Cancer Res; 1996 Aug; 56(15):3399-403. PubMed ID: 8758901
[TBL] [Abstract][Full Text] [Related]
22. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas.
Shibata MA; Ito Y; Morimoto J; Kusakabe K; Yoshinaka R; Otsuki Y
J Gene Med; 2006 Mar; 8(3):335-52. PubMed ID: 16345101
[TBL] [Abstract][Full Text] [Related]
23. Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation.
Zhu S; Li S
Methods Mol Biol; 2008; 423():327-37. PubMed ID: 18370211
[TBL] [Abstract][Full Text] [Related]
24. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
25. IL-12 based gene therapy in veterinary medicine.
Pavlin D; Cemazar M; Sersa G; Tozon N
J Transl Med; 2012 Nov; 10():234. PubMed ID: 23171444
[TBL] [Abstract][Full Text] [Related]
26. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
27. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.
Kamensek U; Cemazar M; Lampreht Tratar U; Ursic K; Sersa G
Cancer Immunol Immunother; 2018 May; 67(5):785-795. PubMed ID: 29468364
[TBL] [Abstract][Full Text] [Related]
28. Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).
Osaki T; Hashimoto W; Gambotto A; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
Gene Ther; 1999 May; 6(5):808-15. PubMed ID: 10505105
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
Yu DS; Lee CF; Hsieh DS; Chang SY
Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors.
Cemazar M; Golzio M; Sersa G; Escoffre JM; Coer A; Vidic S; Teissie J
Hum Gene Ther; 2012 Jan; 23(1):128-37. PubMed ID: 21797718
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model.
Shi F; Rakhmilevich AL; Heise CP; Oshikawa K; Sondel PM; Yang NS; Mahvi DM
Mol Cancer Ther; 2002 Sep; 1(11):949-57. PubMed ID: 12481417
[TBL] [Abstract][Full Text] [Related]
32. Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.
Cicchelero L; Denies S; Haers H; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
Vet Comp Oncol; 2017 Dec; 15(4):1187-1205. PubMed ID: 27506827
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of radiotherapy by hyperthermia-regulated gene therapy.
Lohr F; Hu K; Huang Q; Zhang L; Samulski TV; Dewhirst MW; Li CY
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1513-8. PubMed ID: 11121657
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.
Cutrera J; Torrero M; Shiomitsu K; Mauldin N; Li S
Methods Mol Biol; 2008; 423():319-25. PubMed ID: 18370210
[TBL] [Abstract][Full Text] [Related]
35. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.
Torrero M; Li S
Methods Mol Biol; 2008; 423():339-49. PubMed ID: 18370212
[TBL] [Abstract][Full Text] [Related]
36. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.
Chi CH; Wang YS; Lai YS; Chi KH
Anticancer Res; 2003; 23(1A):315-21. PubMed ID: 12680230
[TBL] [Abstract][Full Text] [Related]
37. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
[TBL] [Abstract][Full Text] [Related]
38. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity.
Gao W; Kumar S; Lotze MT; Hanning C; Robbins PD; Gambotto A
J Immunol; 2003 Jan; 170(1):107-13. PubMed ID: 12496389
[TBL] [Abstract][Full Text] [Related]
39. Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation.
Seetharam S; Staba MJ; Schumm LP; Schreiber K; Schreiber H; Kufe DW; Weichselbaum RR
Int J Oncol; 1999 Oct; 15(4):769-73. PubMed ID: 10493960
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene.
Lee SC; Wu CJ; Wu PY; Huang YL; Wu CW; Tao MH
J Biomed Sci; 2003; 10(1):73-86. PubMed ID: 12566989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
